Lincoln, NE, United States of America

Mary Ann Pfannenstiel

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Huvepharma, Inc., Novus International, Inc., Vaxliant, LLC. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Ann Pfannenstiel. Retrieved from https://idiyas.com/inventor/mary-ann-pfannenstiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Leawood, KS (US) (2020)
  • Peachtree City, GA (US) (2021)
  • Lincoln, NE (US) (2002 - 2023)

Company Filing History:


Years Active: 2002-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Mary Ann Pfannenstiel

Introduction

Mary Ann Pfannenstiel is a notable inventor based in Lincoln, NE (US). She has made significant contributions to the field of veterinary medicine and animal health, holding a total of 8 patents. Her work focuses on developing innovative solutions that enhance the health and well-being of animals.

Latest Patents

Among her latest patents is the development of antibiotic-free compositions for the prevention or control of coccidiosis. These compositions contain sporulated coccidial oocysts and are free of antibiotics, utilizing formalin at a concentration sufficient to inhibit microbial growth for at least 12 months while maintaining oocyst viability. Another significant patent involves adjuvant compositions and related methods, which are suited for injectable and transdermal administration. This adjuvant composition generally includes a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. Additionally, a vaccine composition is provided that includes the vaccine composition of the present disclosure and an antigen, along with methods for vaccinating animals and humans.

Career Highlights

Mary Ann has worked with prominent companies in the industry, including Huvepharma, Inc. and Novus International, Inc. Her expertise and innovative approach have made her a valuable asset in the field of animal health.

Collaborations

Throughout her career, Mary Ann has collaborated with notable colleagues such as Timothy J. Miller and Jennifer Albrecht. These collaborations have further enhanced her research and development efforts.

Conclusion

Mary Ann Pfannenstiel's contributions to veterinary medicine through her innovative patents demonstrate her commitment to improving animal health. Her work continues to influence the industry positively, showcasing the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…